Loading...
XNAS
FEED
Market cap427kUSD
Jul 09, Last price  
0.54USD
1D
12.48%
1Q
-67.69%
IPO
-90.83%
Name

Nanovibronix Inc

Chart & Performance

D1W1MN
XNAS:FEED chart
P/E
—
P/S
0.17
EPS
—
Div Yield, %
—
Shrs. gr., 5y
183.59%
Rev. gr., 5y
32.59%
Revenues
3m
-0.20%
94,000166,000211,000203,000147,000229,000239,000318,000530,000623,0001,695,000752,0002,283,0002,558,0002,553,000
Net income
-18m
L+390.82%
-723,000-1,275,000-1,989,000-2,647,000-2,884,000-2,831,000-5,806,000-4,154,000-5,794,000-4,325,000-14,282,000-5,448,000-3,711,000-3,705,000-18,185,000
CFO
-9m
L+272.50%
-547,000-787,000-602,000-900,000-1,480,000-1,533,000-2,182,000-3,550,000-3,874,000-3,391,000-4,367,000-7,035,000-3,602,000-2,516,000-9,372,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield. The company's business activities span across several global markets, such as the United States, Europe, Australia, India, and Israel, in addition to other territories. This enterprise was founded by Harold Jacob and Jona Zumeris in September 2003, and its main corporate office is situated in Tyler, Texas.
URL
https://nanovibronix.com/
IPO date
Apr 24, 2015
Employees
9
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT